| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/11/1992 | WO1992011862A1 Hyperglycemic compositions |
| 07/11/1992 | WO1992011861A1 Use of il-4 to enhance the reparative phase of wound healing and repair and to enhance the healing of infected wounds and the wounds of diabetic mammals |
| 07/11/1992 | CA2058793A1 Method for treatment for pulmonary disease |
| 07/09/1992 | WO1992012243A1 New insulin-like growth factor binding protein (igfbp-6) |
| 07/09/1992 | WO1992011383A1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF$g(a) |
| 07/09/1992 | WO1992011369A1 Hpv39 papillomavirus genome-derived dna sequences, their application to in vitro diagnosis and production of immunogenic compositions |
| 07/09/1992 | WO1992011368A1 A composition used as a therapeutic agent against chronic viral hepatic diseases |
| 07/09/1992 | WO1992011367A2 Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof |
| 07/09/1992 | WO1992011365A1 Liver enriched transcription factor |
| 07/09/1992 | WO1992011359A1 A truncated interleukin-1 receptor gene for the treatment of arthritis |
| 07/09/1992 | WO1992011358A1 Increased expression by a second transferred sequence in transgenic organisms |
| 07/09/1992 | WO1992011289A1 Antigen processing |
| 07/09/1992 | WO1992011288A1 Hexapeptides deriving from aglucoteicoplanin and a process for preparing them |
| 07/09/1992 | WO1992011287A1 Vasopressin and vasotocin derivates |
| 07/09/1992 | WO1992011285A1 Novel tnf peptides |
| 07/09/1992 | WO1992011283A1 Transgenic, cross-linked hemoglobin |
| 07/09/1992 | WO1992011281A1 Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses |
| 07/09/1992 | WO1992011026A1 Neuronal cholinergic differentiation factor |
| 07/09/1992 | WO1992011025A2 Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases |
| 07/09/1992 | WO1992011022A1 Pharmaceutical preparation for pernasal administration |
| 07/09/1992 | WO1992011015A1 Use of host cell phospholipids for inhibiting microbial colonization |
| 07/09/1992 | DE4139418A1 New DNA encoding squamous cell carcinoma antigen - allowing large scale antigen prodn. for use as diagnostic reagent or immunogen, also useful as hybridisation probe |
| 07/09/1992 | CA2100083A1 Insulin-like growth factor binding protein |
| 07/09/1992 | CA2098848A1 Truncated interleukin-1 receptor gene for the treatment of arthritis |
| 07/09/1992 | CA2098818A1 Transgenic, cross-linked hemoglobin |
| 07/09/1992 | CA2098733A1 Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof |
| 07/08/1992 | WO1992011860A1 Topical formulation of cyclosporine |
| 07/08/1992 | EP0494085A1 Monoclonal antibodies binding determinants of gram negative bacteria |
| 07/08/1992 | EP0494078A1 Amides of antibiotic ge 2270 factors |
| 07/08/1992 | EP0494071A2 Trifluoromethylketone tripeptide derivatives |
| 07/08/1992 | EP0493985A1 Wound healing compositions containing fibroblast growth factor and ascorbic acid |
| 07/08/1992 | EP0493779A1 Cloned gene encoding for bacteriocin from pediococcus acidilactici |
| 07/08/1992 | EP0493770A2 Antiherpes compositions |
| 07/08/1992 | EP0493767A2 Synergistic combination for treating herpes infections |
| 07/08/1992 | EP0493686A1 Monoclonal antibodies to glycolipid carbohydrate chains |
| 07/08/1992 | EP0493682A2 Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans |
| 07/08/1992 | EP0493662A1 Use of superoxide dismutase for the preparation of drugs for the prophylaxis and/or treatment of organ failure in risk patients having a polytrauma due to an accident |
| 07/08/1992 | EP0493588A1 Analogs of hirudin |
| 07/08/1992 | EP0493506A1 Chimeric amino acids and peptides containing these analogues |
| 07/08/1992 | EP0493498A1 Medicament comprising antamanide |
| 07/08/1992 | EP0493494A1 New proteins suitable for combating disease and for protecting grazing cattle from ticks |
| 07/08/1992 | EP0493485A1 Erection-inducing methods and compositions |
| 07/08/1992 | EP0493444A1 Blood-brain barrier model |
| 07/08/1992 | EP0493418A1 Method of producing fusion proteins. |
| 07/08/1992 | EP0493380A1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs. |
| 07/08/1992 | EP0487617A4 Synthetic peptides that enhance cell binding |
| 07/08/1992 | EP0485486A4 Process for disinfecting musculoskeletal tissue and tissues prepared thereby |
| 07/08/1992 | EP0469036A4 Composition and treatment with biologically active peptides and antibiotic |
| 07/08/1992 | EP0455719A4 Composition and treatment with peptide combinations |
| 07/08/1992 | EP0448704A4 Osteogenic devices |
| 07/08/1992 | EP0323462B1 Use of interleukin-1 to induce development of multipotent hemopoietic cell populations |
| 07/08/1992 | EP0300021B1 A process for treating infertility and an agent for use in the process |
| 07/08/1992 | EP0202282B1 New use of 1,4-dihydropyridine derivatives |
| 07/08/1992 | CN1062536A Retroviral protease inhibitors derived from 3-chloro-2-chloromethyl-1-propene |
| 07/08/1992 | CN1062528A Benzodiazepinone |
| 07/08/1992 | CN1017337B Process for preparing phosphinic acid derivatives |
| 07/08/1992 | CA2077647A1 Topical formulation of cyclosporine |
| 07/07/1992 | US5128460 Recombinant trichosanthin and coding sequence |
| 07/07/1992 | US5128453 Urinary follicle stimulating hormone |
| 07/07/1992 | US5128452 Process for the production of crosslinked hemoglobin in the presence of sodium tripolyphosphate |
| 07/07/1992 | US5128450 Bone marrow |
| 07/07/1992 | US5128447 Synthetic peptide antagonists of neurokinin a, salts thereof and respective preparation processes |
| 07/07/1992 | US5128360 Method and agents for inhibiting protein aging |
| 07/07/1992 | US5128322 Agent for therapy |
| 07/07/1992 | US5128321 PDGF analogs and methods of use |
| 07/07/1992 | US5128320 Method of restoring normal growth, weight gain or lean body mass in patients with glucocorticoid excess by administering igf-i |
| 07/07/1992 | US5128258 Iron-releasing monokines |
| 07/07/1992 | US5128242 Hormone release |
| 07/07/1992 | US5128130 Hybrid Bacillus thuringiensis gene, plasmid and transformed Pseudomonas fluorescens |
| 07/07/1992 | US5128126 Use of pharmaceutical compositions containing at least one cytokine for the systemic treatment of preneoplastic lesions |
| 07/07/1992 | US5128122 Nitrogen compound |
| 07/07/1992 | CA1304704C Production of interferon gamma |
| 07/05/1992 | WO1992012169A1 Pseudomonas peptide composition and method for producing the same |
| 07/04/1992 | WO1992011844A1 Stabilization of proteins by cationic biopolymers |
| 07/04/1992 | CA2099376A1 Stabilization of proteins by cationic biopolymers |
| 07/03/1992 | WO1992012237A1 Fusions of a viral protein and a destructive enzyme |
| 07/02/1992 | DE4041114A1 IgG2a antibody fraction from body fluid of HIV patients - obtd. during latent phase of infection, deep frozen and re-administered, used for AIDS treatment |
| 07/01/1992 | EP0493037A2 Method of treating thromboembolic disorders |
| 07/01/1992 | EP0492964A2 Cloning and expression of Borrelia lipoproteins |
| 07/01/1992 | EP0492614A2 Epitheliocyte growth accelerator |
| 07/01/1992 | EP0492560A2 Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of HIV-1, and related peptides |
| 07/01/1992 | EP0492536A2 Method for the production of pathogen resistant plants |
| 07/01/1992 | EP0492530A1 Monoclonal antibodies which bind mannose binding protein |
| 07/01/1992 | EP0492478A2 Tert-butyloxycarbonyl-L-tyrosyl-peptidoglycan monomer and 125 I-labelled derivative thereof, their preparation and use |
| 07/01/1992 | EP0492448A1 Monoclonal antibodies against human tumor necrosis factor alpha |
| 07/01/1992 | EP0492409A1 Human monoclonal antibody |
| 07/01/1992 | EP0492369A1 Novel amino and nitro containing tricyclic compounds useful as inhibitors of ace |
| 07/01/1992 | EP0492214A2 Human Interleukin-5 receptor |
| 07/01/1992 | EP0492179A2 Avian growth hormone receptor and binding protein |
| 07/01/1992 | EP0492136A2 Retroviral protease inhibitors derived from 3-chloro-2-chloromethyl-1-propene |
| 07/01/1992 | EP0491888A1 Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection |
| 07/01/1992 | EP0491873A1 Therapeutic compositions; methods for treatment of hiv infections |
| 07/01/1992 | EP0491849A1 A method for the purification of transforming growth factor (tgf-). |
| 07/01/1992 | EP0491828A1 PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP), DIAGNOSTIC AND THERAPEUTIC USE THEREOF |
| 07/01/1992 | EP0491757A1 Process for inactivating viruses in blood and blood products |
| 07/01/1992 | EP0491755A1 Gamma glutamyl transferases for treating diseases |
| 07/01/1992 | EP0256090B1 Solubilization of hydrophobic materials using lysophospholipid |
| 06/30/1992 | US5126433 Glycoprotein which can form complex with human immunodeficiency virus envelope glyprotein |
| 06/30/1992 | US5126399 Methods and compositions for the preparation and use of site-directed immunologic reagents |
| 06/30/1992 | US5126327 Oligo- or polypeptide |